Related Experiment Video
Updated: Nov 6, 2025

Real-Time Cardiac Mapping with a Noninvasive Imageless Electrocardiographic Imaging System
Published on: April 11, 2025
Artificial intelligence-enabled fully automated detection of cardiac amyloidosis using electrocardiograms and
Shinichi Goto1,2,3, Keitaro Mahara4, Lauren Beussink-Nelson5
1One Brave Idea and Division of Cardiovascular Medicine, Department of Medicine, Brigham and Women's Hospital, Boston, MA, USA.
Insights
Artificial intelligence (AI) models can now detect cardiac amyloidosis (CA) using electrocardiograms (ECG) or echocardiograms, improving early diagnosis for this rare heart condition.
Area of Science:
- Cardiology
- Medical Imaging
- Artificial Intelligence in Medicine
Background:
- Rare cardiac conditions like cardiac amyloidosis (CA) present diagnostic challenges due to overlapping symptoms with common disorders.
- Delayed diagnosis of CA hinders timely access to approved therapies.
- Artificial intelligence (AI) offers potential for early detection of rare diseases.
Purpose of the Study:
- To develop and validate an AI-driven pipeline for detecting cardiac amyloidosis (CA).
- To assess the performance of AI models using electrocardiograms (ECG) and echocardiograms as input data.
- To evaluate the potential of AI in improving the diagnostic pathway for CA.
Main Methods:
- Developed AI models utilizing ECG and echocardiogram data for CA detection.
- Trained and validated models across multiple academic medical centers (AMCs).
- Simulated real-world deployment scenarios to assess predictive value and recall.
Main Results:
- AI models achieved high C-statistics for CA detection: 0.85-0.91 for ECG and 0.89-1.00 for echocardiography.
- Simulated deployment showed a positive predictive value (PPV) of 3-4% for the ECG model at 52-71% recall.
- Pre-screening with ECG significantly enhanced echocardiography model performance, increasing PPV from 33% to 74-77% at 67% recall.
Conclusions:
- An automated AI strategy was developed to enhance the detection of cardiac amyloidosis.
- The AI pipeline demonstrates potential for improving diagnostic efficiency in rare cardiac diseases.
- The developed approach is expected to be generalizable to other rare cardiac conditions.
Abstract:
Patients with rare conditions such as cardiac amyloidosis (CA) are difficult to identify, given the similarity of disease manifestations to more prevalent disorders. The deployment of approved therapies for CA has been limited by delayed diagnosis of this disease. Artificial intelligence (AI) could enable detection of rare diseases. Here we present a pipeline for CA detection using AI models with electrocardiograms (ECG) or echocardiograms as inputs. These models, trained and validated on 3 and 5 academic medical centers (AMC) respectively, detect CA with C-statistics of 0.85-0.91 for ECG and 0.89-1.00 for echocardiography. Simulating deployment on 2 AMCs indicated a positive predictive value (PPV) for the ECG model of 3-4% at 52-71% recall. Pre-screening with ECG enhance the echocardiography model performance at 67% recall from PPV of 33% to PPV of 74-77%. In conclusion, we developed an automated strategy to augment CA detection, which should be generalizable to other rare cardiac diseases.
Related Concept Videos
Acute Coronary Syndrome III: Diagnostic Studies
Dysrhythmias V: Evaluating Dysrhythmias
Imaging Studies for Cardiovascular System I:Echocardiography
Indications: Echocardiography is utilized to diagnose heart failure, valve disorders, and myocardial infarction. It also assesses cardiac structures' size, shape, and motion,...
Electrocardiogram
Three major waveforms are present in a typical ECG recording: the P wave, the QRS complex, and...
Cardiomyopathy III: Hypertrophic Cardiomyopathy

